Literature DB >> 15338525

Rapid reversal of renal failure after initiation of HAART: a case report.

Danielle Scheurer1.   

Abstract

HIV-associated nephropathy (HIVAN), characterized by proteinuria and progressive renal failure, is a well-known complication of HIV infection. Treatment of the condition has focused on the use of corticosteroids, angiotensin-converting enzyme inhibitors, and HAART, all of which can improve the prognosis. Although there are a few case reports of improvement of renal function after the initiation of HAART, this treatment has not been studied in a prospective fashion, and the timing of the improvement is not well documented. Presented here is a case of rapid reversal of end-stage renal failure after the initiation of HAART in a person with biopsy-proven HIVAN.

Entities:  

Mesh:

Year:  2004        PMID: 15338525

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  4 in total

Review 1.  HIV-associated renal disorders: recent insights into pathogenesis and treatment.

Authors:  Ruth Berggren; Vecihi Batuman
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

2.  Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Authors:  Amanda Mocroft; Christina Wyatt; Lynda Szczech; Jacquie Neuhaus; Wafaa El-Sadr; Russell Tracy; Lewis Kuller; Michael Shlipak; Brian Angus; Harting Klinker; Michael Ross
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

3.  Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.

Authors:  Bonaventura C T Mpondo; Samuel E Kalluvya; Robert N Peck; Rodrick Kabangila; Benson R Kidenya; Lucheri Ephraim; Daniel W Fitzgerald; Jennifer A Downs
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

Review 4.  Update on current management of chronic kidney disease in patients with HIV infection.

Authors:  Nina E Diana; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.